Furthermore, among the biomarkers FGFR2, VEGF, and TRAIL-R1 and TRAIL-R2 investigated in the present study, FGFR2 was the only one that predicted HCC recurrence. The gene discussed is TNFRSF10A; the disease is hepatocellular carcinoma.